X-9688093-C-T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_005647.4(TBL1X):​c.434C>T​(p.Thr145Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000331 in 1,209,918 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000034 ( 0 hom. 8 hem. )

Consequence

TBL1X
NM_005647.4 missense

Scores

2
3
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.42
Variant links:
Genes affected
TBL1X (HGNC:11585): (transducin beta like 1 X-linked) The protein encoded by this gene has sequence similarity with members of the WD40 repeat-containing protein family. The WD40 group is a large family of proteins, which appear to have a regulatory function. It is believed that the WD40 repeats mediate protein-protein interactions and members of the family are involved in signal transduction, RNA processing, gene regulation, vesicular trafficking, cytoskeletal assembly and may play a role in the control of cytotypic differentiation. This encoded protein is found as a subunit in corepressor SMRT (silencing mediator for retinoid and thyroid receptors) complex along with histone deacetylase 3 protein. This gene is located adjacent to the ocular albinism gene and it is thought to be involved in the pathogenesis of the ocular albinism with late-onset sensorineural deafness phenotype. Four transcript variants encoding two different isoforms have been found for this gene. This gene is highly similar to the Y chromosome TBL1Y gene. [provided by RefSeq, Nov 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.12903115).
BS2
High Hemizygotes in GnomAdExome4 at 8 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TBL1XNM_005647.4 linkc.434C>T p.Thr145Met missense_variant Exon 7 of 18 ENST00000645353.2 NP_005638.1 O60907-1A0A024RBV9
TBL1XNM_001139466.1 linkc.434C>T p.Thr145Met missense_variant Exon 7 of 18 NP_001132938.1 O60907-1A0A024RBV9
TBL1XNM_001139467.1 linkc.281C>T p.Thr94Met missense_variant Exon 6 of 17 NP_001132939.1 O60907-2
TBL1XNM_001139468.1 linkc.281C>T p.Thr94Met missense_variant Exon 7 of 18 NP_001132940.1 O60907-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TBL1XENST00000645353.2 linkc.434C>T p.Thr145Met missense_variant Exon 7 of 18 NM_005647.4 ENSP00000496215.1 O60907-1

Frequencies

GnomAD3 genomes
AF:
0.0000267
AC:
3
AN:
112432
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000323
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000939
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000281
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000335
AC:
6
AN:
179352
AF XY:
0.0000154
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000110
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000379
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000337
AC:
37
AN:
1097432
Hom.:
0
Cov.:
32
AF XY:
0.0000220
AC XY:
8
AN XY:
362886
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26373
American (AMR)
AF:
0.0000853
AC:
3
AN:
35151
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19361
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54001
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40450
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4136
European-Non Finnish (NFE)
AF:
0.0000368
AC:
31
AN:
841726
Other (OTH)
AF:
0.0000651
AC:
3
AN:
46062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000267
AC:
3
AN:
112486
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34654
show subpopulations
African (AFR)
AF:
0.0000322
AC:
1
AN:
31028
American (AMR)
AF:
0.0000938
AC:
1
AN:
10658
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2661
East Asian (EAS)
AF:
0.000282
AC:
1
AN:
3552
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2697
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6196
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53262
Other (OTH)
AF:
0.00
AC:
0
AN:
1527
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000302
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000346
AC:
1
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
May 06, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.434C>T (p.T145M) alteration is located in exon 7 (coding exon 4) of the TBL1X gene. This alteration results from a C to T substitution at nucleotide position 434, causing the threonine (T) at amino acid position 145 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.35
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.28
.;T;.;T;T;T;T;.;.
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.86
D;D;.;.;.;.;.;D;D
M_CAP
Benign
0.044
D
MetaRNN
Benign
0.13
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.78
T
MutationAssessor
Uncertain
2.7
.;M;.;M;M;M;M;.;.
PhyloP100
5.4
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-1.0
N;N;N;N;.;.;.;.;.
REVEL
Benign
0.075
Sift
Benign
0.11
T;T;T;T;.;.;.;.;.
Sift4G
Benign
0.12
T;T;T;T;.;.;.;.;.
Polyphen
0.14
.;B;.;B;B;B;B;.;.
Vest4
0.68
MutPred
0.25
.;Gain of MoRF binding (P = 0.0696);.;Gain of MoRF binding (P = 0.0696);Gain of MoRF binding (P = 0.0696);Gain of MoRF binding (P = 0.0696);Gain of MoRF binding (P = 0.0696);.;.;
MVP
0.58
MPC
0.78
ClinPred
0.16
T
GERP RS
4.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.11
gMVP
0.83
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs779865031; hg19: chrX-9656133; COSMIC: COSV99482869; COSMIC: COSV99482869; API